Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Valproic Acid and Dihydroergotamine as Abortive Therapy in Pediatric Migraine
NCT03885154Phase 2Terminated
- Start
- Oct 2017
- Primary completion
- Mar 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of valproic acid, dihydroergotamine in migraine. Started Oct 2017; status: terminated.
02
Drugs
valproic aciddihydroergotamine
03
Conditions
migraine
Beyond the preview
Go deeper on NCT03885154.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03885154.